Sem J. Aronson

579 total citations
13 papers, 319 citations indexed

About

Sem J. Aronson is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Molecular Biology. According to data from OpenAlex, Sem J. Aronson has authored 13 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Sem J. Aronson's work include Neonatal Health and Biochemistry (5 papers), Virus-based gene therapy research (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Sem J. Aronson is often cited by papers focused on Neonatal Health and Biochemistry (5 papers), Virus-based gene therapy research (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Sem J. Aronson collaborates with scholars based in Netherlands, France and Italy. Sem J. Aronson's co-authors include Piter J. Bosma, Thijs van de Laar, Janke Schinkel, Ulrich Beuers, Suzanne Duijst, Hendrik W. Reesink, Giuseppe Ronzitti, Maria Prins, Richard Molenkamp and Sylvie M. Koekkoek and has published in prestigious journals such as New England Journal of Medicine, Journal of Virology and Scientific Reports.

In The Last Decade

Sem J. Aronson

13 papers receiving 312 citations

Peers

Countries citing papers authored by Sem J. Aronson

Since Specialization

Citations

This map shows the geographic impact of Sem J. Aronson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sem J. Aronson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sem J. Aronson more than expected).

Fields of papers citing papers by Sem J. Aronson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sem J. Aronson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sem J. Aronson. The network helps show where Sem J. Aronson may publish in the future.

Co-authorship network of co-authors of Sem J. Aronson

This figure shows the co-authorship network connecting the top 25 collaborators of Sem J. Aronson. A scholar is included among the top collaborators of Sem J. Aronson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sem J. Aronson. Sem J. Aronson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Gene Therapy in Patients with the Crigler–Najjar Syndrome 2023 ·New England Journal of Medicine ·Lorenzo D’Antiga, Ulrich Beuers, Giuseppe Ronzitti, Nicola Brunetti‐Pierri, Ulrich Baumann, Angelo Di Giorgio, Sem J. Aronson, (unknown), Roberta Romano, Norman Junge, Piter J. Bosma, Giulia Bortolussi, Andrés F. Muro, (unknown), P. Véron, Fanny Collaud, (unknown), Philippe Labrune, Federico Mingozzi	32
2	Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated With Disease Severity: A Retrospective Cohort Study 2022 ·Open Forum Infectious Diseases ·Dennis Souverein, Karlijn J. van Stralen, (unknown), (unknown), (unknown), Dominic Snijders, Robin Soetekouw, (unknown), Evelien de Jong, (unknown), Sem J. Aronson, Bjorn L. Herpers, (unknown), Alex Wagemakers, Sjoerd M. Euser	6
3	SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: a retrospective cross-sectional cohort study 2021 ·International Journal of Epidemiology ·Sjoerd M. Euser, Sem J. Aronson, (unknown), (unknown), Bjorn L. Herpers, J. C. Sinnige, Jayant Kalpoe, (unknown), Dominic Snijders, Ruud Jansen, (unknown), Marlies van Houten, (unknown), James Cohen Stuart, (unknown), (unknown), (unknown), Elisabeth A. M. Sanders, Alex Wagemakers, Dennis Souverein	34
4	A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene 2020 ·Molecular Therapy — Methods & Clinical Development ·Sem J. Aronson, (unknown), (unknown), Remco van Dijk, Giulia Bortolussi, Fanny Collaud, Xiaoxia Shi, Suzanne Duijst, Lysbeth ten Bloemendaal, Giuseppe Ronzitti, Andrés F. Muro, Federico Mingozzi, Ulrich Beuers, Piter J. Bosma	14
5	Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients 2020 ·Molecular Therapy — Methods & Clinical Development ·Xiaoxia Shi, Sem J. Aronson, Lysbeth ten Bloemendaal, Suzanne Duijst, (unknown), (unknown), Giulia Bortolussi, Fanny Collaud, Ronald P.J. Oude Elferink, Andrés F. Muro, Federico Mingozzi, Giuseppe Ronzitti, Piter J. Bosma	15
6	A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report 2019 ·BMC Pediatrics ·Xiaoxia Shi, Sem J. Aronson, (unknown), Piter J. Bosma	4
7	Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice 2019 ·Journal of Hepatology ·Sem J. Aronson, (unknown), Xiaoxia Shi, Suzanne Duijst, Lysbeth ten Bloemendaal, Dirk R. de Waart, Joanne Verheij, Giuseppe Ronzitti, Ronald P.J. Oude Elferink, Ulrich Beuers, Coen C. Paulusma, Piter J. Bosma	37
8	Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome 2019 ·Human Gene Therapy ·Sem J. Aronson, P. Véron, Fanny Collaud, (unknown), (unknown), Géraldine Honnet, Robert J. de Knegt, Norman Junge, Ulrich Baumann, Angelo Di Giorgio, Lorenzo D’Antiga, (unknown), Nicola Brunetti‐Pierri, Philippe Labrune, Ulrich Beuers, Piter J. Bosma, Federico Mingozzi	43
9	Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo 2017 ·Scientific Reports ·Remco van Dijk, Sem J. Aronson, Dirk R. de Waart, Stan F.J. van de Graaf, Suzanne Duijst, Jurgen Seppen, Ronald Oude Elferink, Ulrich Beuers, Piter J. Bosma	19
10	Disruption of HNF1α binding site causes inherited severe unconjugated hyperbilirubinemia 2015 ·Journal of Hepatology ·Remco van Dijk, Isabel Mayayo‐Peralta, Sem J. Aronson, (unknown), (unknown), (unknown), Nevin Oruç, Ulrich Beuers, Piter J. Bosma	2
11	Colonial History and Contemporary Transmission Shape the Genetic Diversity of Hepatitis C Virus Genotype 2 in Amsterdam 2012 ·Journal of Virology ·Peter V. Markov, Thijs van de Laar, Xiomara V. Thomas, Sem J. Aronson, Christine J. Weegink, (unknown), M. Prins, Oliver G. Pybus, Janke Schinkel	41
12	Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological Profiles 2009 ·Journal of Clinical Microbiology ·Joep de Bruijne, Janke Schinkel, Maria Prins, Sylvie M. Koekkoek, Sem J. Aronson, (unknown), Hendrik W. Reesink, Richard Molenkamp, Thijs van de Laar	64
13	Thermolysis and Photolysis of C₆₀Diozonides 2005 ·Fullerenes Nanotubes and Carbon Nanostructures ·D. Heymann, Sergei M. Bachilo, Sem J. Aronson	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact